<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2005-06-13" updated="2020-01-02">
  <drugbank-id primary="true">DB04494</drugbank-id>
  <drugbank-id>EXPT02435</drugbank-id>
  <name>Dihydroxy(oxo)molybdenum(6+)</name>
  <description/>
  <cas-number/>
  <unii/>
  <average-mass>145.95</average-mass>
  <monoisotopic-mass>147.905801776</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication/>
  <pharmacodynamics/>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as transition metal oxides. These are inorganic compounds containing an oxygen atom of an oxidation state of -2, in which the heaviest atom bonded to the oxygen is a transition metal.</description>
    <direct-parent>Transition metal oxides</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Transition metal organides</class>
    <subclass>Transition metal oxides</subclass>
    <alternative-parent>Inorganic oxides</alternative-parent>
    <alternative-parent>Inorganic salts</alternative-parent>
    <substituent>Inorganic oxide</substituent>
    <substituent>Inorganic salt</substituent>
    <substituent>Transition metal oxide</substituent>
  </classification>
  <salts/>
  <synonyms/>
  <products/>
  <international-brands/>
  <mixtures/>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories/>
  <affected-organisms/>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1n60</pdb-entry>
    <pdb-entry>1p0z</pdb-entry>
    <pdb-entry>6rkd</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1.4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>dihydroxy(oxo)molybdenumhexakis(ylium)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>mo(vi)(=O)(oh)2 cluster</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>145.95</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>147.905801776</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>O[Mo+6](O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>H2MoO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/Mo.2H2O.O/h;2*1H2;/q+8;;;/p-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>GKDPEXRCAVYDOG-UHFFFAOYSA-L</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>57.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>6.57</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>5.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>2.7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507185</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>58829657</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>OMO</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0001941</id>
      <name>Sensor histidine kinase CitA</name>
      <organism>Klebsiella pneumoniae</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A1713</ref-id>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <ref-id>A1715</ref-id>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P52687" source="Swiss-Prot">
        <name>Sensor histidine kinase CitA</name>
        <general-function>Phosphorelay sensor kinase activity</general-function>
        <specific-function>Member of the two-component regulatory system CitA/CitB. Probably activates CitB by phosphorylation. The periplasmic domain binds H-citrate(2-), which is essential for induction of the citrate-fermentation genes.</specific-function>
        <gene-name>citA</gene-name>
        <locus/>
        <cellular-location>Cell inner membrane</cellular-location>
        <transmembrane-regions>24-44
181-201</transmembrane-regions>
        <signal-regions/>
        <theoretical-pi>6.8</theoretical-pi>
        <molecular-weight>61779.46</molecular-weight>
        <chromosome-location/>
        <organism ncbi-taxonomy-id="573">Klebsiella pneumoniae</organism>
        <external-identifiers>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>U31464</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>924991</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P52687</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>CITA_KLEPN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>2.7.13.3</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016619|Sensor histidine kinase CitA
MSIYPMYTRKITHWFARRSFQNRIFLLILFTSTIVMLAMSWYLTDITEERLHYQVGQRAL
IQAMQISAMPELVEAVQKRDLARIKALIDPMRSFSDATYITVGDASGQRLYHVNPDEIGK
SMEGGDSDEALINAKSYVSVRKGSLGSSLRGKSPIQDATGKVIGIVSVGYTIEQLENWLS
LQISSLLIPMAIMLLLLLFCARRFSLHIKKQMLNMEPQQLSQLLIQQSVLFESVFEGLIA
IDSDYKITAINQTARRLLNLSQPEPTLIGKRISSVISQEVFFYDAPQTNKKDEIVTFNQI
KVIASRMAVILNNEPQGWVISFRSKDDINTLSLQLSQVQQYADNLRAVQHEHRNLISTIA
GLLFLKRYNQALELIQQQSESHQKVIDFIARNFQDNHLAGLLIGKYYRAKELGLELIFDP
ACFVDRLPTALSHNEWISIVGNLLDNAYNASLRQPQGSKQIECLINSDGQEVIIEIADQG
CGIDEALRDRIFERGVTSSASKDHGIGLWLVRSYVEQAGGSIVVENNIPFGTIFTLYIPL
TRDEHHG</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0003844|1644 bp
ATGTCTATCTACCCAATGTATACCCGAAAAATCACCCACTGGTTTGCCAGGCGATCGTTT
CAGAATCGCATCTTCCTGCTGATCTTATTCACCTCGACGATCGTCATGCTGGCGATGTCA
TGGTATCTGACAGACATTACCGAGGAGCGTCTGCATTATCAGGTCGGGCAACGGGCGCTG
ATTCAGGCGATGCAGATTTCGGCGATGCCGGAGCTGGTGGAGGCAGTGCAGAAACGCGAT
CTCGCCAGAATCAAAGCCCTTATCGACCCCATGCGTTCGTTCTCCGACGCCACCTACATC
ACCGTCGGTGATGCCAGCGGCCAGCGCCTCTATCACGTCAATCCTGATGAAATCGGCAAA
TCGATGGAAGGCGGCGATAGCGATGAGGCGTTGATAAACGCTAAAAGCTACGTGTCAGTG
CGCAAAGGCTCGCTGGGATCGTCGCTGCGCGGTAAATCGCCGATTCAGGACGCAACCGGC
AAGGTGATCGGCATTGTGTCGGTAGGCTATACCATTGAGCAACTGGAAAACTGGCTCAGC
CTGCAGATAAGTTCGCTGCTGATCCCGATGGCCATCATGTTACTGCTTCTGCTCTTTTGC
GCCCGCCGCTTCTCACTGCATATCAAAAAACAGATGCTCAATATGGAACCCCAGCAGCTG
TCACAGCTGTTGATCCAGCAAAGCGTGCTGTTTGAATCGGTGTTCGAAGGGCTTATCGCC
ATCGACTCCGATTATAAAATCACTGCGATTAATCAGACTGCGCGTCGCCTGCTCAATTTG
AGTCAGCCGGAACCGACGCTTATCGGCAAACGGATCAGCAGCGTTATCTCGCAGGAGGTC
TTCTTCTACGATGCGCCACAGACCAATAAAAAAGACGAGATCGTTACCTTCAATCAGATC
AAAGTGATCGCCAGCCGGATGGCGGTGATCTTAAACAATGAGCCACAGGGCTGGGTGATC
AGCTTTCGCAGCAAAGACGATATCAACACCCTTAGCCTGCAGCTTAGCCAGGTACAACAA
TATGCCGATAACCTGCGCGCCGTACAGCATGAGCATCGCAATCTGATCTCCACTATCGCC
GGTCTGCTGTTTCTTAAACGCTATAACCAAGCGCTGGAACTTATCCAACAGCAGTCGGAA
AGTCACCAGAAGGTGATCGATTTTATTGCACGCAATTTCCAGGACAACCACCTGGCCGGG
CTGTTGATCGGCAAATATTACCGGGCCAAAGAGCTTGGACTTGAGCTGATTTTCGATCCG
GCCTGCTTCGTTGATAGATTACCTACCGCCCTTTCGCACAACGAATGGATCTCGATCGTG
GGGAATCTACTTGATAACGCCTACAATGCCAGCCTGCGTCAACCGCAGGGTTCAAAACAG
ATCGAATGCCTGATCAACAGTGATGGCCAGGAGGTGATCATTGAGATCGCCGACCAGGGA
TGCGGCATTGACGAGGCGCTGCGCGATCGGATCTTCGAGCGCGGCGTCACCAGCAGCGCC
AGCAAAGATCATGGTATCGGACTCTGGCTAGTACGCAGCTACGTGGAACAAGCAGGCGGC
AGTATCGTCGTCGAAAATAATATTCCTTTTGGCACCATTTTTACGCTTTATATCCCCCTG
ACCCGAGATGAACATCATGGATAG</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF02518</identifier>
            <name>HATPase_c</name>
          </pfam>
          <pfam>
            <identifier>PF14827</identifier>
            <name>Cache_3</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>intracellular</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATP binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>phosphorelay sensor kinase activity</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>